Back
IRulya Therapeutics Inc. IRLA · Transcripts
website
IRulya Therapeutics is a clinical-stage biopharmaceutical company developing LAM-001, an inhaled for...38
Price33.775
Market Cap366.22 M
Float10.8 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents